The DOI matches its Crossref record; 136 of the 138 references it cites were found in a registry or an index, and 2 are not checked yet.
Liver fibrosis
Open accessAbstract
Liver fibrosis is the excessive accumulation of extracellular matrix proteins including collagen that occurs in most types of chronic liver diseases. Advanced liver fibrosis results in cirrhosis, liver failure, and portal hypertension and often requires liver transplantation. Our knowledge of the cellular and molecular mechanisms of liver fibrosis has greatly advanced. Activated hepatic stellate cells, portal fibroblasts, and myofibroblasts of bone marrow origin have been identified as major collagen-producing cells in the injured liver. These cells are activated by fibrogenic cytokines such as TGF-beta1, angiotensin II, and leptin. Reversibility of advanced liver fibrosis in patients has been recently documented, which has stimulated researchers to develop antifibrotic drugs. Emerging antifibrotic therapies are aimed at inhibiting the accumulation of fibrogenic cells and/or preventing the deposition of extracellular matrix proteins. Although many therapeutic interventions are effective in experimental models of liver fibrosis, their efficacy and safety in humans is unknown. This review summarizes recent progress in the study of the pathogenesis and diagnosis of liver fibrosis and discusses current antifibrotic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The current study amends this fibrocentric concept by demonstrating fibrosis-independent roles for HSCs through RSPO3, regulating critical parameters that affect CLD progression and outcomes, including metabolic hepatocyte functions, liver regeneration and hepatocyte death2,49,50.”
From Hepatic stellate cells control liver zonation, size and functions via R-spondin 3 (2025) · cites this paper as [2]
In the citing paper
“In more advanced disease stages, the ECM can replace functional liver parenchyma and thereby contribute to the development of liver cirrhosis, which is characterized by bridging fibrosis, regenerative nodules, and the loss of liver function [230].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · cites this paper as [230]
In the citing paper
“Two of the prototype cytokines responsible for the activation of HSCs during liver injury are the transforming growth factor-β (TGF-β) and the platelet-derived growth factor (PDGF).[3]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
The Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,414
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Thomas, A. C., & Campbell, J. H. (2000) · Cited by 2,800
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci20530 · Cited by 2,715
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,171
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
Regev, A., Berho, M. E., Jeffers, L. J., Milikowski, C., Molina, E. G., Pyrsopoulos, N., Feng, Z.-Z., Reddy, K. R., & Schiff, E. R. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.06038.x · Cited by 2,078
Xu, D., He, X., Chang, Y., Sun, S., Xu, C., & Lin, J. (2012) · Hepatogastroenterology · doi:10.5754/hge12458 · Cited by 1,977
Liver fibrosis – from bench to bedside
Friedman, S. L. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00429-4 · Cited by 1,780
Flagged first, then by citations
Research works printed but not linked: 9
- Soyer, 1976, Surgery., 79, 601
- Otto, 1980, Adv. Exp. Med. Biol., 132, 509
- Wasser, 1999, Ann. Acad. Med. Singapore., 28, 109
- Brunt, 2004, Semin. Liver Dis., 24, 3
- Phillips, 2004, J. Clin. Invest., 114, 438, 10.1172/jci200420997 · DOI
- Kmiec, 2001, Adv. Anat. Embryol. Cell Biol., 161, III–XIII, 1–151
- Thurman, 1998, Am. J. Physiol., 275, G605
- Wei, 2000, World J. Gastroenterol., 6, 540
- Tuncer, 2003, Exp. Toxicol. Pathol., 55, 159
Cited by
Sorted by citations
Items 501–600 of 1,040
Forbes, S. J., & Parola, M. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.02.006 · Cited by 115
Sripa, B., Thinkhamrop, B., Mairiang, E., Laha, T., Kaewkes, S., Sithithaworn, P., Periago, M. V., Bhudhisawasdi, V., Yonglitthipagon, P., Mulvenna, J. P., et al. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001654 · Cited by 115
p53 on the crossroad between regeneration and cancer
Charni‐Natan, M., Aloni-Grinstein, R., Molchadsky, A., & Rotter, V. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.117 · Cited by 115
Mesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis
Koyama, Y., Wang, P., Liang, S., Iwaisako, K., Liu, X., Xu, J., Zhang, M., Sun, M., Cong, M., Karin, D., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88845 · Cited by 115
Self-citationPlatelets contribute to the reduction of liver fibrosis in mice
Watanabe, M., Murata, S., Hashimoto, I., Nakano, Y., Ikeda, O., Aoyagi, Y., Matsuo, R., Fukunaga, K., Yasue, H., & Ohkohchi, N. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05497.x · Cited by 115
Cytokines and STATs in Liver Fibrosis
Kong, X., Horiguchi, N., Mori, M., & Gao, B. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00069 · Cited by 115
Hypoxia, angiogenesis and liver fibrogenesis in the progression of chronic liver diseases
Paternostro, C. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i3.281 · Cited by 115
General mechanisms of nicotine‐induced fibrogenesis
Jensen, K. J., Nizamutdinov, D., Guerrier, M., Afroze, S. H., Dostal, D. E., & Glaser, S. S. (2012) · The FASEB Journal · doi:10.1096/fj.12-206458 · Cited by 115
Mesenchymal stem cells in fibrotic diseases—the two sides of the same coin
Qin, L., Liu, N., Bao, C.-L.-M., Yang, D.-Z., Ma, G.-X., Yi, W.-H., Xiao, G.-Z., & Cao, H.-L. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00952-0 · Cited by 114
Mimicking dynamic in vivo environments with stimuli-responsive materials for cell culture
Kim, J., & Hayward, R. C. (2012) · Trends in biotechnology · doi:10.1016/j.tibtech.2012.04.003 · Cited by 114
Morán‐Salvador, E., Titos, E., Rius, B., González‐Périz, A., García‐Alonso, V., López‐Vicario, C., Miquel, R., Barak, Y., Arroyo, V., & Clària, J. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.06.023 · Cited by 114
Muriel, P., & Arauz, J. (2009) · Fitoterapia · doi:10.1016/j.fitote.2009.10.003 · Cited by 114
Magee, N. S., Zou, A., & Zhang, Y. (2016) · BioMed Research International · doi:10.1155/2016/5170402 · Cited by 114
Platelets in liver disease, cancer and regeneration
Kurokawa, T., & Ohkohchi, N. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i18.3228 · Cited by 114
Radeke, M. J., Radeke, C. M., Shih, Y.-H., Hu, J. G., Bok, D., Johnson, L. V., & Coffey, P. J. (2015) · Genome Medicine · doi:10.1186/s13073-015-0183-x · Cited by 114
Peng, Z., Fernández, P., Wilder, T., Yee, H. T., Chiriboga, L. A., Chan, E. S. L., & Cronstein, B. N. (2008) · The FASEB Journal · doi:10.1096/fj.07-100685 · Cited by 114
Wang, M., Chen, Y., Chen, I.-S., Hsieh, S., Chen, S., & Chiu, C. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.08.004 · Cited by 114
Cui, W., Matsuno, K., Iwata, K., Ibi, M., Matsumoto, M., Zhang, J., Zhu, K., Katsuyama, M., Torok, N. J., & Yabe‐Nishimura, C. (2011) · Hepatology · doi:10.1002/hep.24465 · Cited by 113
Chun, Y. S., Chaudhari, P., & Jang, Y.-Y. (2010) · International Journal of Biological Sciences · doi:10.7150/ijbs.6.796 · Cited by 113
Gu, L., Tao, X., Xu, Y., Han, X., Qi, Y., Xu, L., Yin, L., & Peng, J. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.12.024 · Cited by 113
Matsuda, M., Tsurusaki, S., Miyata, N., Saijou, E., Okochi, H., Miyajima, A., & Tanaka, M. (2017) · Hepatology · doi:10.1002/hep.29421 · Cited by 113
Leu, J. I.-J., Murphy, M. E., & George, D. L. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821277116 · Cited by 113
Tissue Engineering in Liver Regenerative Medicine: Insights into Novel Translational Technologies
Heydari, Z., Najimi, M., Mirzaei, H., Shpichka, A. I., Ruoß, M., Farzaneh, Z., Montazeri, L., Piryaei, A., Timashev, P. S., Gramignoli, R., et al. (2020) · Cells · doi:10.3390/cells9020304 · Cited by 113
Molecular MR imaging of liver fibrosis: A feasibility study using rat and mouse models
Polášek, M., Fuchs, B. C., Uppal, R., Schühle, D. T., Alford, J. K., Loving, G. S., Yamada, S., Wei, L., Lauwers, G. Y., Guimarães, A. R., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.04.035 · Cited by 113
Schwabe, R. F., & Brenner, D. A. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01068-6 · Cited by 112
Self-citationLanger, D., Das, A., Semela, D., Kang, N., Hendrickson, H. I., Bronk, S. F., Katušić, Z. S., Gores, G. J., & Shah, V. H. (2008) · Hepatology · doi:10.1002/hep.22285 · Cited by 112
The stellate cell system (vitamin A-storing cell system)
Senoo, H., Mezaki, Y., & Fujiwara, M. (2017) · Anatomical Science International · doi:10.1007/s12565-017-0395-9 · Cited by 112
Caputo, T., Gilardi, F., & Desvergne, B. (2017) · FEBS Letters · doi:10.1002/1873-3468.12742 · Cited by 112
D’Ambrosio, D. N., Walewski, J. L., Clugston, R. D., Berk, P. D., Rippe, R. A., & Blaner, W. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024993 · Cited by 112
Yan, A. W. (2012) · World Journal of Hepatology · doi:10.4254/wjh.v4.i4.110 · Cited by 112
Li, R., Xu, L., Liang, T., Li, Y., Zhang, S., & Duan, X. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.10.059 · Cited by 111
Hepatic Stellate Cells May Relate to Progression of Intrahepatic Cholangiocarcinoma
Okabe, H., Beppu, T., Hayashi, H., Horino, K., Masuda, T., Komori, H., Ishikawa, S., Watanabe, M., Takamori, H., Iyama, K.-I., et al. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0568-4 · Cited by 111
Lin, J., Tang, Y., Kang, Q., Feng, Y., & Chen, A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01910.x · Cited by 111
Calcium Signaling in the Liver
Amaya, M. J., & Nathanson, M. H. (2012) · Comprehensive physiology · doi:10.1002/cphy.c120013 · Cited by 111
Hepatic stellate cells control liver zonation, size and functions via R-spondin 3
Sugimoto, A., Saito, Y., Wang, G., Sun, Q., Yin, C., Lee, K. H., Geng, Y., Rajbhandari, P., Hernandez, C., Steffani, M., et al. (2025) · Nature · doi:10.1038/s41586-025-08677-w · Cited by 133
Self-citationLi, W., Chen, C., Xu, M., Guo, J., Li, Y., Xia, Q., Liu, H., He, J., Yu, H., & Zhu, L. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08075.x · Cited by 110
Li, J.-P., Gao, Y., Chu, S., Zhang, Z., Xia, C., Mou, Z., Song, X., He, W., Guo, X., & Chen, N. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.41 · Cited by 110
Clinical Advancements in the Targeted Therapies against Liver Fibrosis
Bansal, R., Nagórniewicz, B., & Prakash, J. (2016) · Mediators of Inflammation · doi:10.1155/2016/7629724 · Cited by 110
Liu, N., Meng, Z., Lou, G., Zhou, W., Wang, X., Zhang, Y., Zhang, L., Liu, X., Yen, Y., Lai, L. L., et al. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1383 · Cited by 110
The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease
Hartmann, P., Chen, W., & Schnabl, B. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00402 · Cited by 110
Foo, N., Lin, S.-H., Lee, Y., Wu, M., & Wang, Y. (2011) · Toxicology · doi:10.1016/j.tox.2011.01.009 · Cited by 109
Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis
Qu, C., Zheng, D., Li, S., Liu, Y., Lidofsky, A., Holmes, J. A., Chen, J., He, L., Wei, L., Liao, Y., et al. (2018) · Hepatology · doi:10.1002/hep.29881 · Cited by 109
Wei, L., Chen, Q., Guo, A., Fan, J., Wang, R., & Zhang, H. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.04.016 · Cited by 109
Li, J., Wang, Y., Ma, M., Jiang, S., Zhang, X., Zhang, Y., Yang, X., Xu, C., Tian, G.-A., Li, Q., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2019.01.009 · Cited by 109
Yan, J., Tung, H., Li, S., Niu, Y., Garbacz, W. G., Lu, P., Bi, Y., Li, Y., He, J., Xu, M., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.05.066 · Cited by 109
High-Throughput Glycomic Methods
Trbojević‐Akmačić, I., Lageveen‐Kammeijer, G. S. M., Heijs, B., Pribić, T., Deriš, H., Wuhrer, M., & Lauc, G. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c01031 · Cited by 109
THE ROLE OF GENETIC POLYMORPHISMS IN ALCOHOLIC LIVER DISEASE
Stickel, F., & Österreicher, C. (2006) · Alcohol and Alcoholism · doi:10.1093/alcalc/agl011 · Cited by 109
Thyroid hormones inhibit TGF-β signaling and attenuate fibrotic responses
Alonso-Merino, E., Martín Orozco, R., Ruíz-Llorente, L., Martínez-Iglesias, O. A., Velasco-Martín, J. P., Montero-Pedrazuela, A., Fanjul-Rodríguez, L., Contreras-Jurado, C., Regadera, J., & Aranda, A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1506113113 · Cited by 108
Leeming, D. J., Karsdal, M. A., Byrjalsen, I., Bendtsen, F., Trebicka, J., Nielsen, M. J., Christiansen, C., Møller, S., & Krag, A. A. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12484 · Cited by 108
Non-invasive detection of liver fibrosis: MR imaging features vs. MR elastography
Venkatesh, S. K., Yin, M., Takahashi, N., Glockner, J. F., Talwalkar, J. A., & Ehman, R. L. (2015) · Abdominal Imaging · doi:10.1007/s00261-015-0347-6 · Cited by 108
The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells
Martín‐Vílchez, S., Sanz-Cameno, P., Rodríguez-Muñoz, Y., Majano, P. L., Molina‐Jiménez, F., López‐Cabrera, M., Moreno‐Otero, R., & Lara‐Pezzi, E. (2008) · Hepatology · doi:10.1002/hep.22265 · Cited by 108
Fibrosis is a common outcome following total knee arthroplasty
Abdul, N., Dixon, D., Walker, A. F., Horabin, J., Smith, N., Weir, D. J., Brewster, N., Deehan, D. J., Mann, D. A., & Borthwick, L. A. (2015) · Scientific Reports · doi:10.1038/srep16469 · Cited by 108
Massó-Vallés, D., Jauset, T., Serrano, E., Sodir, N. M., Pedersen, K., Affara, N. I., Whitfield, J. R., Beaulieu, M.-È., Evan, G. I., Elias, L., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2852 · Cited by 108
Fedirko, V., Duarte‐Salles, T., Bamia, C., Trichopoulou, A., Aleksandrova, K., Trichopoulos, D., Trépo, E., Tjønneland, A. M., Olsen, A., Overvad, K., et al. (2014) · Hepatology · doi:10.1002/hep.27079 · Cited by 108
Chen, Q., Zhang, H., Cao, Y. W., Li, Y., Sun, S., Zhang, J., & Zhang, G. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s137507 · Cited by 108
Mi, X.-J., Hou, J., Jiang, S., Liu, Z., Tang, S., Liu, X., Wang, Y., Chen, C., Wang, Z., & Li, W. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b05943 · Cited by 108
T1 mapping, T2 mapping and MR elastography of the liver for detection and staging of liver fibrosis
Hoffman, D. H., Ayoola, A., Nickel, D. M., Han, F., Chandarana, H., & Shanbhogue, K. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-02382-9 · Cited by 108
Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip
Goto, K., Suarez, A. A. R., Wrensch, F., Baumert, T. F., & Lupberger, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093057 · Cited by 108
Oncogenic driver genes and tumor microenvironment determine the type of liver cancer
Wang, G., Wang, Q., Liang, N. N., Xue, H., Yang, T., Chen, X., Qiu, Z., Zeng, C., Sun, T., Yuan, W., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2509-x · Cited by 108
Hepatic myofibroblasts: A heterogeneous population of multifunctional cells in liver fibrogenesis
Novo, E., di Bonzo, L. V., Cannito, S., Colombatto, S., & Parola, M. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.03.010 · Cited by 108
Moles, A., Tarrats, N., Fernández-Checa, J. C., & Marı́, M. (2008) · Hepatology · doi:10.1002/hep.22753 · Cited by 108
Molecular Mechanisms of Liver Fibrosis in HIV/HCV Coinfection
Mastroianni, C. M., Lichtner, M., Mascia, C., Zuccalà, P., & Vullo, V. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069184 · Cited by 108
Reversibility of Liver Fibrosis and Inactivation of Fibrogenic Myofibroblasts
Liu, X., Xu, J., Brenner, D. A., & Kisseleva, T. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-013-0018-7 · Cited by 108
Self-citationXiao, J., Ching, Y. P., Liong, E. C., Nanji, A. A., Fung, M., & Tipoe, G. L. (2012) · European Journal of Nutrition · doi:10.1007/s00394-012-0301-0 · Cited by 108
Pereira, R. M., Santos, R. A. S., Teixeira, M. M., Leite, V. H. R., Costa, L. P., Dias, F. L. D. C., Barcelos, L. S., Collares, G. B., & Silva, A. C. S. E. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.10.018 · Cited by 108
Lee, Y. J., Lee, J. M., Lee, J. E., Lee, K. B., Lee, E. S., Yoon, J., Yu, M. H., Baek, J. H., Shin, C. I., Han, J. K., et al. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24147 · Cited by 107
Obesity: An Immunometabolic Perspective
Ray, I., Mahata, S. K., & De, R. K. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00157 · Cited by 107
Yang, F., Luo, L., Zhu, Z., Zhou, X., Wang, Y., Xue, J., Zhang, J., Cai, X., Chen, Z.-L., Ma, Q., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00929 · Cited by 107
Wu, X., Shu, L., Zhang, Z., Li, J., Zong, J., Cheong, L. Y., Ye, D., Lam, K. S. L., Song, E., Wang, C., et al. (2021) · Advanced Science · doi:10.1002/advs.202003721 · Cited by 107
Liver fibrosis: An intravoxel incoherent motion (IVIM) study
Chow, A. M., Gao, D. S., Fan, S. J., Qiao, Z., Lee, F. Y., Yang, J., Man, K., & Wu, E. X. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23607 · Cited by 107
Omenetti, A., & Diehl, A. M. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00543.2007 · Cited by 107
Jiang, S., Zhang, Y., Zheng, J., Li, X., Yao, Y., Wu, Y., Song, S., Sun, P., Nan, J., & Lian, L. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.040 · Cited by 106
Tang, W., Zhao, Z., Chong, Y., Wu, C., Liu, Q., Yang, J., Zhou, R., Lian, Z., & Liang, G. (2018) · ACS Nano · doi:10.1021/acsnano.8b04143 · Cited by 106
TGF-β1 Gene Silencing for Treating Liver Fibrosis
Cheng, K., Yang, N., & Mahato, R. I. (2009) · Molecular Pharmaceutics · doi:10.1021/mp9000469 · Cited by 106
Latella, G., Vetuschi, A., Sferra, R., Catitti, V., D’Angelo, A., Zanninelli, G., Flanders, K. C., & Gaudio, E. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02011.x · Cited by 106
Nan, Y., Wu, W., Fu, N., Liang, B.-L., Wang, R., Li, L.-X., Zhao, S., Zhao, J., & Yu, J. Q. (2009) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520903114912 · Cited by 106
Zhang, Y., Wu, L., Wang, Y., Zhang, M., Li, L., Zhu, D., Li, X., Gu, H., Zhang, C., & Zen, K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.314922 · Cited by 106
Roderburg, C., Mollnow, T., Bongaerts, B. W. C., Elfimova, N., Cardenas, D. V., Janssen, K., Zimmermann, H. W., Koch, A. H., Vucur, M., Luedde, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032999 · Cited by 105
Liu, C., Chen, X., Yang, L., Kisseleva, T., Brenner, D. A., & Seki, E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.543769 · Cited by 105
Self-citationTian, X.-F., Ji, F., Zang, H.-L., & Cao, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158657 · Cited by 105
Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma
Chauhan, R., & Lahiri, N. (2016) · Biomarkers in Cancer · doi:10.4137/bic.s34413 · Cited by 105
Targeting Senescent Cells in Fibrosis: Pathology, Paradox, and Practical Considerations
Schafer, M. J., Haak, A. J., Tschumperlin, D. J., & LeBrasseur, N. K. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0712-x · Cited by 106
Clinical prediction of HBV and HCV related hepatic fibrosis using machine learning
Wei, R., Wang, J., Wang, X., Xie, G., Wang, Y., Zhang, H., Peng, C., Rajani, C., Kwee, S. A., Liu, P., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.07.041 · Cited by 105
Liu, M., Yang, H., & Mao, Y. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.09.70 · Cited by 105
Zhang, Q., Qu, Y., Zhang, Q., Li, F., Li, B., Li, Z., Dong, Y., Lu, L., & Cai, X. (2022) · Cell Biology and Toxicology · doi:10.1007/s10565-021-09684-z · Cited by 105
Dong, J., Chen, L., Ye, F., Tang, J., Liu, B., Lin, J., Zhou, P., Lü, B., Wu, M., Lu, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44057-6 · Cited by 105
In vitro and in vivo antifibrotic effects of rosmarinic acid on experimental liver fibrosis
Li, G., Jiang, W., Tian, J., Qu, G., Zhu, H., & Fu, F. (2009) · Phytomedicine · doi:10.1016/j.phymed.2009.05.002 · Cited by 105
Effects and mechanisms of crude astragalosides fraction on liver fibrosis in rats
Gui, S., Wei, W., Wang, H., Wu, L., Sun, W., Chen, W., & Wu, C. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2005.07.025 · Cited by 105
The innate immune receptor TREM-1 promotes liver injury and fibrosis
Nguyen-Lefebvre, A. T., Ajith, A., Portik-Dobos, V., Horuzsko, D. D., Arbab, A. S., Dzutsev, A., Sadek, R., Trinchieri, G., & Horuzsko, A. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98156 · Cited by 104
Szuster‐Ciesielska, A., Plewka, K., Daniluk, J., & Kandefer‐Szerszeń, M. (2010) · Toxicology · doi:10.1016/j.tox.2010.12.006 · Cited by 104
Yu, F., Jiang, Z., Chen, B., Dong, P., & Zheng, J. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1586-5 · Cited by 104
Ikawa‐Yoshida, A., Matsuo, S., Kato, A., Ohmori, Y., Higashida, A., Kaneko, E., & Matsumoto, M. (2017) · International Journal of Experimental Pathology · doi:10.1111/iep.12240 · Cited by 104
Jin, Z., Sun, R., Wei, H., Gao, X., Chen, Y., & Tian, Z. (2010) · Hepatology · doi:10.1002/hep.23983 · Cited by 104
Immune Interactions in Hepatic Fibrosis
Holt, A. P., Salmon, M., Buckley, C. D., & Adams, D. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.002 · Cited by 104
Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C
Vidali, M., Tripodi, M., Ivaldi, A., Zampino, R., Occhino, G., Restivo, L., Sutti, S., Marrone, A., Ruggiero, G., Albano, E., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.10.011 · Cited by 104
Grace, J., Herath, C. B., Mak, K. Y., Burrell, L. M., & Angus, P. (2012) · Clinical Science · doi:10.1042/cs20120030 · Cited by 104
Ikenaga, N., Liu, S. B., Sverdlov, D., Yoshida, S., Nasser, I. A., Ke, Q., Kang, P. M., & Popov, Y. V. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.10.013 · Cited by 104
Role of integrins in fibrosing liver diseases
Patsenker, E., & Stickel, F. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00050.2011 · Cited by 104
Role of oxidative stress in the pathogenesis of alcohol-induced liver disease
Sid, B., Verrax, J., & Calderón, P. B. (2013) · Free Radical Research · doi:10.3109/10715762.2013.819428 · Cited by 104
Ricci, E., Vanosi, G., Lindenmair, A., Hennerbichler, S., Peterbauer-Scherb, A., Wolbank, S., Cargnoni, A., Signoroni, P. B., Campagnol, M., Gabriel, C., et al. (2012) · Cell and Tissue Banking · doi:10.1007/s10561-012-9337-x · Cited by 104
Metadata
- Authors
- Bataller, R., & Brenner, D. A.
- Affiliations
- Columbia University (US)
- Corresponding author
- Brenner, David A.
- ORCID
- Brenner, David A.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-02-01
- Volume
- 115
- Issue
- 2
- Pages
- 209-218
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4255712601
- Cited by
- 4,958
- References
- 134
- Citations by year
- 2026: 177 · 2025: 236 · 2024: 285 · 2023: 289 · 2022: 307 · 2021: 321 · 2020: 294 · 2019: 275 · 2018: 284 · 2017: 295 · 2016: 281 · 2015: 307 · 2014: 229 · 2013: 224 · 2012: 222
- FWCI
- 17.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministerio de Ciencia y Tecnología
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- liver fibrosis, extracellular matrix accumulation, collagen deposition, chronic liver disease, liver cirrhosis, hepatic stellate cells, portal fibroblasts, myofibroblasts, TGF-β1, angiotensin II, leptin, fibrogenic cytokines, antifibrotic agents, fibrosis pathogenesis, fibrosis diagnosis, liver transplantation
- MeSH terms
- Angiotensin II, Animals, Humans, Hypertension, Portal, Liver Cirrhosis, Transforming Growth Factor beta, Liver Failure, Leptin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review